Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial

被引：0
|
作者：
Bartolomé R. Celli
Marc Decramer
Dacheng Liu
Norbert Metzdorf
Guus M. Asijee
Donald P. Tashkin
机构：
[1] Brigham and Women’s Hospital,Pulmonary Division
[2] University of Leuven,undefined
[3] Boehringer Ingelheim Pharmaceuticals Inc,undefined
[4] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
[5] David Geffen School of Medicine UCLA,undefined
来源：
Respiratory Research | / 17卷
关键词：
Exacerbation; COPD; Mortality; Composite endpoint; Outcomes; Discontinuation; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF PLECANATIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION: RESULTS FROM 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIALS
    Fogel, Ronald
    Dorn, Spencer D.
    Krause, Richard
    Eng, Paul
    KIrshoff, Robert
    Nguyen, Anhthu
    Griffin, Patrick
    GASTROENTEROLOGY, 2017, 152 (05) : S1309 - S1310
  • [32] Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials
    Wilens, Timothy E.
    Gault, Laura M.
    Childress, Ann
    Kratochvil, Christopher J.
    Bensman, Lindsey
    Hall, Coleen M.
    Olson, Evelyn
    Robieson, Weining Z.
    Garimella, Tushar S.
    Abi-Saab, Walid M.
    Apostol, George
    Saltarelli, Mario D.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (01): : 73 - 84
  • [33] Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial
    Hanania, Nicola A.
    Boota, Ahmad
    Kerwin, Edward
    Tomlinson, LaTanya
    Denis-Mize, Kimberly
    DRUGS, 2009, 69 (09) : 1205 - 1216
  • [34] Stiripentol in Dravet syndrome Additional results from two randomized placebo-controlled clinical trials
    Serraz, B.
    Guerrini, R.
    Chancharme, L.
    Chiron, C.
    EPILEPSIA, 2024, 65 : 218 - 219
  • [35] SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL
    Mullen, K.
    Sigal, S.
    Sheikh, M.
    Bass, N.
    Poordad, F.
    Merchant, K.
    Huang, S.
    Shaw, A.
    Bortey, E.
    Forbes, W.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S84 - S85
  • [36] The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD A Randomized Placebo-Controlled Trial
    Hanania, Nicola A.
    Feldman, Gregory
    Zachgo, Wolfgang
    Shim, Jae-Jeong
    Crim, Courtney
    Sanford, Lisa
    Lettis, Sally
    Barnhart, Frank
    Haumann, Brett
    CHEST, 2012, 142 (01) : 119 - 127
  • [37] Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study
    Zheng, Jinping
    Zhong, Nanshan
    Newlands, Amy
    Church, Alison
    Goh, Aik H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1753 - 1767
  • [38] A randomized, placebo-controlled trial of bronchodilators for bronchoscopy in patients with COPD
    Stolz, Daian
    Pollak, Vincent
    Chhajed, Prashant N.
    Gysin, Christian
    Pflimlin, Eric
    Tamm, Michael
    CHEST, 2007, 131 (03) : 765 - 772
  • [39] Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial
    Lee, Sang-Do
    Hui, David S. C.
    Mahayiddin, Aziah A.
    Roa, Camilo C., Jr.
    Kwa, Kheng Hoe
    Goehring, Udo-Michael
    Bredenbroeker, Dirk
    Kuo, Han-Pin
    RESPIROLOGY, 2011, 16 (08) : 1249 - 1257
  • [40] A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
    Weiss, Daniel J.
    Casaburi, Richard
    Flannery, Robin
    LeRoux-Williams, Michelle
    Tashkin, Donald P.
    CHEST, 2013, 143 (06) : 1590 - 1598
12345